Literature DB >> 8145058

Hypophyseal non-Hodgkin's lymphoma presenting with clinical panhypopituitarism successfully treated with chemotherapy.

A R Jonkhoff1, P C Huijgens, W O Schreuder, G J Teule, J J Heimans.   

Abstract

A patient is described with a testicular Non-Hodgkin's Lymphoma (NHL) presenting with panhypopituitarism caused by a hypophyseal localization. A 67Gallium scintigraphy showed avid uptake in the hypophyseal region. Obviously 67Gallium could reach the tumor, by the intravenous route, which was the reason to treat the patient with intravenous chemotherapy. A complete remission was induced, which seems to be lasting (+25 months). As far as we know this is the first report of panhypopituitarism caused by a hypophyseal NHL in the hypophysis and successfully treated by intravenous chemotherapy.

Entities:  

Mesh：

Year:  1993        PMID： 8145058     DOI： 10.1007/bf01050217

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  11 in total

1.  Residual mass and negative gallium scintigraphy in treated lymphoma: when is the gallium scan really negative?

Authors:  W D Kaplan
Journal:  J Nucl Med       Date:  1990-03       Impact factor: 10.057

2.  [The hypophysis and haemoblastoses].

Authors:  E Buchmann; G Schwesinger
Journal:  Zentralbl Neurochir       Date:  1979

3.  Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis.

Authors:  L Recht; D J Straus; C Cirrincione; H T Thaler; J B Posner
Journal:  Am J Med       Date:  1988-03       Impact factor: 4.965

Review 4.  Cavernous sinus syndrome as the presentation of malignant lymphoma: case report and review of the literature.

Authors:  E S Delpassand; J B Kirkpatrick
Journal:  Neurosurgery       Date:  1988-10       Impact factor: 4.654

5.  Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone.

Authors:  M Brada; D Dearnaley; A Horwich; H J Bloom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-04       Impact factor: 7.038

6.  Combined modality therapy for primary CNS lymphoma.

Authors:  L M DeAngelis; J Yahalom; H T Thaler; U Kher
Journal:  J Clin Oncol       Date:  1992-04       Impact factor: 44.544

7.  Primary lymphoma of the central nervous system. An unresolved therapeutic problem.

Authors:  G Socié; C Piprot-Chauffat; M Schlienger; D Legars; C Thurel; J Mikol; N Ifran; J Brière; F Pene; B Gindrey-Vie
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

8.  Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate.

Authors:  T Ervin; G P Canellos
Journal:  Cancer       Date:  1980-04-01       Impact factor: 6.860

9.  Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

Authors:  E A Neuwelt; D L Goldman; S A Dahlborg; J Crossen; F Ramsey; S Roman-Goldstein; R Braziel; B Dana
Journal:  J Clin Oncol       Date:  1991-09       Impact factor: 44.544

10.  Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases.

Authors:  F R MacKintosh; T V Colby; W J Podolsky; J S Burke; R T Hoppe; F P Rosenfelt; S A Rosenberg; H S Kaplan
Journal:  Cancer       Date:  1982-02-01       Impact factor: 6.860
View more
  10 in total

1.  Hypophyseal non-Hodgkin's lymphoma presenting with diabetes insipidus: a case report.

Authors:  E M Merlo; A Maiolo; A Brocchieri; A Tua; G Grignani
Journal:  J Neurooncol       Date:  1999-03       Impact factor: 4.130

Review 2.  Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease.

Authors:  C Megan Ogilvie; Sarah Payne; Jane Evanson; T Andrew Lister; Ashley B Grossman
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

3.  Non-Hodgkin lymphoma with panhypopituitarism, hyperprolactinaemia and sixth nerve palsy.

Authors:  J A Shaw; F M Strachan; H A Sawers; J S Bevan
Journal:  J R Soc Med       Date:  1997-05       Impact factor: 5.344

4.  A relapsed non-Hodgkin lymphoma presenting as panhypopituitarism successfully treated by chemotherapy.

Authors:  Tomas Büchler; Christelle Ferra; Nuria Virgili; Eduard Montanya; Albert Grañena
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

5.  Diffuse large B-cell non Hodgkin's lymphoma in a 65-year-old woman presenting with hypopituitarism and recovering after chemotherapy: a case report.

Authors:  Manohara Kenchaiah; Steve L Hyer
Journal:  J Med Case Rep       Date:  2011-10-04

6.  Methotrexate-associated lymphoproliferative disorder with hypopituitarism and central diabetes insipidus.

Authors:  Misaki Aoshima; Koji Nagayama; Kei Takeshita; Hiroshi Ajima; Sakurako Orikasa; Ayana Iwazaki; Hiroaki Takatori; Yutaka Oki
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-10-12

7.  Pituitary infiltration by non-Hodgkin's lymphoma: a case report.

Authors:  Gonca Tamer; Ilkay Kartal; Ferihan Aral
Journal:  J Med Case Rep       Date:  2009-11-24

8.  Clinical features of patients with non-Hodgkin's lymphoma metastasizing to the pituitary glands.

Authors:  Junjie Yang; Na Zhao; Guangsen Zhang; Wenli Zheng
Journal:  Oncol Lett       Date:  2013-03-19       Impact factor: 2.967

9.  Malignant lymphoma in the parasellar region.

Authors:  Takao Koiso; Hiroyoshi Akutsu; Shingo Takano; Tetsuya Yamamoto; Eiichi Ishikawa; Yasushi Okoshi; Akira Matsumura
Journal:  Case Rep Med       Date:  2014-02-10

10.  Pituitary and adrenal involvement in diffuse large B-cell lymphoma, with recovery of their function after chemotherapy.

Authors:  Yasuhiro Nakashima; Motoaki Shiratsuchi; Ichiro Abe; Yayoi Matsuda; Noriyuki Miyata; Hirofumi Ohno; Motohiko Ikeda; Takamitsu Matsushima; Masatoshi Nomura; Ryoichi Takayanagi
Journal:  BMC Endocr Disord       Date:  2013-10-09       Impact factor: 2.763
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.